The FDA issued yesterday (8/5) Emergency Use Authorization for Vela Diagnostics for the manual version of their COVID-19 PCR test. The manual version of the test enables flexible sample processing, facilitating widespread use of the test throughout the United States. Sam Dajani, interim CEO and Chairman of the Board for Vela Diagnostics, said, “RT-PCR is currently the gold standard for diagnosing SARS-CoV-2 infections. Given the escalating number of COVID-19 cases in the U.S., Vela Diagnostics is helping Americans get tested so as to detect and slow the spread of the virus. Our coronavirus test will assist healthcare professionals in managing the COVID-19 pandemic.” 

Read more here

More on: